Nanalysis Scientific Corp. (NSCIF)

Market Cap	12.95M -37.2%
Revenue (ttm)	28.80M -10.5%
Net Income	-4.03M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	15.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Open	0.1020
Previous Close	0.0934
Day's Range	0.0934 - 0.1020
52-Week Range	0.0800 - 0.1950
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2026

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides softw...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: OTCMKTS
• Ticker Symbol: NSCIF

Financial Performance

In 2025, Nanalysis Scientific's revenue was 40.13 million, a decrease of -11.79% compared to the previous year's 45.50 million. Losses were -5.66 million, -58.44% less than in 2024.

Financial numbers in CAD